A. David Rodrigues

2.4k citations

49 papers · 1.8k indexed · h-index 26

Pharmacology top 0.2%
Oncology top 5%
Molecular Biology
Pediatrics, Perinatology and Child Health top 5%
Surgery

Co-authors: Zheng Yang Michael Sinz Hongjian Zhang Andrew Rowland Yong–Hae Han Michael J. Sorich Jawaher Abdullah Alamoudi Cliff Chen
Topics: Drug Transport and Resistance Mechanisms (31 papers)Pharmacogenetics and Drug Metabolism (31 papers)Pharmacological Effects and Toxicity Studies (12 papers)
Cited by: Pharmacology Oncology Pediatrics, Perinatology and Child Health
Journals: Journal of Medicinal Chemistry Archives of Biochemistry and Biophysics Biochemical Pharmacology
Partner nations: United States Germany Australia

In The Last Decade

A. David Rodrigues

49 papers receiving 1.8k citations

Peers

Countries citing papers authored by A. David Rodrigues

Since Specialization

Citations

This map shows the geographic impact of A. David Rodrigues's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. David Rodrigues with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. David Rodrigues more than expected).

Fields of papers citing papers by A. David Rodrigues

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. David Rodrigues. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. David Rodrigues. The network helps show where A. David Rodrigues may publish in the future.

Co-authorship network of co-authors of A. David Rodrigues

This figure shows the co-authorship network connecting the top 25 collaborators of A. David Rodrigues. A scholar is included among the top collaborators of A. David Rodrigues based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. David Rodrigues. A. David Rodrigues is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesicles 2023 ·PROTEOMICS ·Zivile Useckaite,Lauren A. Newman,Ashley M. Hopkins,Sonja Klebe,Alex D. Colella,(unknown),Ruth Williams,Michael J. Sorich,A. David Rodrigues,Tim Chataway,Andrew Rowland	3
2	Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and Disposition 2021 ·Drug Metabolism and Disposition ·Zivile Useckaite,A. David Rodrigues,Ashley M. Hopkins,Lauren A. Newman,Jillian G. Johnson,Michael J. Sorich,Andrew Rowland	15
3	Evidence-Based Guidelines for Drug Interaction Studies: Model-Informed Time Course of Intestinal and Hepatic CYP3A4 Inhibition by Clarithromycin 2021 ·The AAPS Journal ·(unknown),Ahmad Y. Abuhelwa,Michael J. Sorich,Ross A. McKinnon,A. David Rodrigues,Andrew Rowland,Ashley M. Hopkins	10
4	Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate 2019 ·Frontiers in Pharmacology ·Madelé van Dyk,(unknown),Ashley M. Hopkins,A. David Rodrigues,Manoli Vourvahis,Michael J. Sorich,Andrew Rowland	6
5	Plasma extracellular nanovesicle (exosome)‐derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure 2018 ·British Journal of Clinical Pharmacology ·Andrew Rowland,(unknown),Madelé van Dyk,Dhilushi Wijayakumara,Linda S. Wood,Robyn Meech,Peter I. Mackenzie,A. David Rodrigues,Jean‐Claude Marshall,Michael J. Sorich	62
6	Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanisticin vitroAssays 2015 ·Toxicological Sciences ·Falgun Shah,Louis Leung,Hugh A. Barton,Yvonne Will,A. David Rodrigues,Nigel Greene,Michael D. Aleo	106
7	Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions 2013 ·Drug Metabolism and Disposition ·Yoshiyuki Shirasaka,(unknown),Mary F. Grubb,(unknown),Kenneth E. Thummel,Nina Isoherranen,A. David Rodrigues	27
8	Development of Novel, 384-Well High-Throughput Assay Panels for Human Drug Transporters: Drug Interaction and Safety Assessment in Support of Discovery Research 2013 ·SLAS DISCOVERY ·Huaping Tang,Ding Ren Shen,Yong–Hae Han,Yan Kong,Praveen Balimane,Anthony M. Marino,Mian Gao,(unknown),Dianlin Xie,Matthew G. Soars,Jonathan C. O’Connell,A. David Rodrigues,(unknown),Mary Ellen Cvijic	13
9	Drug-Induced Perturbations of the Bile Acid Pool, Cholestasis, and Hepatotoxicity: Mechanistic Considerations beyond the Direct Inhibition of the Bile Salt Export Pump 2013 ·Drug Metabolism and Disposition ·A. David Rodrigues,Yurong Lai,Mary Ellen Cvijic,Lisa Elkin,Tatyana Zvyaga,Matthew G. Soars	86
10	Development of a Carbon-14 Labeling Approach to Support Disposition Studies with a Pegylated Biologic 2012 ·Drug Metabolism and Disposition ·Haiqing Wang,Lifei Wang,Kai Cao,Stuart L. Emanuel,Paul E. Morin,Zheng Lin,Guoxiang Shen,(unknown),Donglu Zhang,Samuel J. Bonacorsi,A. David Rodrigues,Zheng Yang	5
11	Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19 2012 ·Drug Metabolism and Disposition ·Tatyana Zvyaga,Shu‐Ying Chang,Cliff Chen,Zheng Yang,Ragini Vuppugalla,(unknown),(unknown),Andrew J. Wagner,Anjaneya Chimalakonda,A. David Rodrigues	99
12	Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in rats 2012 ·Xenobiotica ·Ragini Vuppugalla,Yueping Zhang,Shu Chang,A. David Rodrigues,Punit H. Marathe	10
13	Transporter Studies with the 3-O-Sulfate Conjugate of 17α-Ethinylestradiol: Assessment of Human Liver Drug Transporters 2010 ·Drug Metabolism and Disposition ·Yong–Hae Han,Dennis E. Busler,Hong Yang,Yuan Tian,Cliff Chen,A. David Rodrigues	53
14	A liquid chromatography tandem mass spectrometry method for the quantification of indocyanine green in dog plasma and bile 2008 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown),(unknown),Qian Ruan,Punit Marathe,A. David Rodrigues,Zheng Yang	16
15	Pharmacokinetic Drug Interactions Involving 17??-Ethinylestradiol 2007 ·Clinical Pharmacokinetics ·Hongjian Zhang,Donghui Cui,Bonnie Wang,Yong–Hae Han,Praveen Balimane,Zheng Yang,Michael Sinz,A. David Rodrigues	143
16	Projection of Exposure and Efficacious Dose Prior to First-in-Human Studies: How Successful Have We Been? 2007 ·Pharmaceutical Research ·Christine Huang,Ming Zheng,Zheng Yang,A. David Rodrigues,Punit Marathe	16
17	Prioritization of Clinical Drug Interaction Studies Using In Vitro Cytochrome P450 Data:“Rank Order” Approach 2007 ·Drug Metabolism Letters ·A. David Rodrigues	16
18	Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductase 2006 ·Archives of Biochemistry and Biophysics ·Bo Wen,Jed N. Lampe,Arthur G. Roberts,William M. Atkins,A. David Rodrigues,Sidney D. Nelson	16
19	Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey 2005 ·European Journal of Pharmaceutical Sciences ·Magang Shou,Wei Lü,Prasad H. Kari,Cathie Xiang,Yuexia Liang,Ping Lü,Dan Cui,(unknown),(unknown),(unknown),(unknown),A. David Rodrigues	21
20	Application of Human Liver Microsomes in Metabolism-Based Drug-Drug Interactions: In Vitro-in Vivo Correlations and the Abbott Laboratories Experience 1997 ·Advances in pharmacology ·A. David Rodrigues,Shekman Wong	27

About A. David Rodrigues

A. David Rodrigues is a scholar working on Pharmacology, Oncology and Transplantation, having authored 49 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (31 papers), Pharmacogenetics and Drug Metabolism (31 papers) and Pharmacological Effects and Toxicity Studies (12 papers). The work is most often cited by research in Pharmacology (924 citations), Oncology (772 citations) and Pediatrics, Perinatology and Child Health (328 citations). A. David Rodrigues has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Zheng Yang, Michael Sinz, Hongjian Zhang, Andrew Rowland, Yong–Hae Han, Michael J. Sorich, Jawaher Abdullah Alamoudi, Cliff Chen, Rhishikesh Thakare and Nagsen Gautam. Their work appears in journals such as Journal of Medicinal Chemistry, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact